Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

PNRC1 Activators

PNRC1 activators encompass a range of chemicals centered on modulating intracellular signaling cascades, particularly those associated with cAMP, calcium levels, and PKC. Among them, agents that elevate cAMP levels, such as Forskolin, Rolipram, and IBMX, present a strategic approach. The rationale behind this is the known interaction between PNRC1 and nuclear receptors. cAMP elevation can intensify nuclear receptor activity, offering an indirect method to influence PNRC1's function and interaction. The implications of this become evident considering other activators like Cilostamide, Milrinone, and Zardaverine, which, through their inhibition of specific PDEs, also contribute to elevated cAMP, further underscoring the importance of this pathway.

Additionally, calcium signaling represents another critical point of intersection. Agents like Thapsigargin and Ionomycin, which modify intracellular calcium concentrations, can influence nuclear receptor functionalities, indirectly affecting PNRC1's modulation and interactions. PKC, another significant pathway, interacts with PNRC1 and serves as a target for activators such as PMA and OAG. The activation of PKC, especially in the context of its relationship with PNRC1, showcases the intricate ties between these intracellular signaling molecules and the broader role of PNRC1 in cellular functions. Through targeted modulation of these pathways, a nuanced understanding of PNRC1 and its activators becomes apparent.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

PP2A inhibitor, which can influence pathways interacting with PNRC1, especially those mediated through PKC.

BAY 60-6583

910487-58-0sc-503262
10 mg
$210.00
(0)

A2A adenosine receptor agonist leading to increased cAMP levels. The enhanced cAMP can further promote nuclear receptor activities, which indirectly affects PNRC1 modulation.